A Study of the Efficacy of the Code Stroke in Spain
- Conditions
- Stroke, Acute
- Interventions
- Procedure: Code Stroke
- Registration Number
- NCT02647957
- Lead Sponsor
- Universidad Miguel Hernandez de Elche
- Brief Summary
Code Stroke is a system for the rapid identification, pre-notification and transport of acute ischemic stroke patients. The objective of this study was to define quality indicators and to compare treatment outcomes in hospitals where Code Stroke has been implemented and hospitals without the use of Code Stroke (control patients).
- Detailed Description
In a first step qualitative technique has been conducted to define treatment quality indicators of acute ischemic stroke patients. In a second step a prospective study is conducted to collect data of 240 inpatients from two groups of hospitals. Two hospitals applying Code Stroke (N= 120) and four hospitals non-applying Code Stroke procedure (N=120). A consecutive sampling method will be conducted. Inclusion criteria: acute ischemic stroke patients treated in the hospitals during the field study. The referral to the hospital could be from primary care, Emergency Unit of other hospital. Patients will enroll after inform consent.
A Singer-blind- research method will applied. Quality indicators defined in the first phase will be applied and comparisons will be realized using ANOVA.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 240
- acute ischemic stroke in-patients
- Patients who refuse participate
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group A Code Stroke Hospital using Code Stroke
- Primary Outcome Measures
Name Time Method Recovery rate of the Intravenous trombolysis treatment 1 month Number of patients showing an adequate recovery after Intravenous trombolysis treatment as assessed by the criteria of the Quality Indicator Board of the German Stroke Registers Study Group and the National Sentinel Audit of Stroke.
- Secondary Outcome Measures
Name Time Method Patient satisfaction 1 month Patient Satisfaction Scale
Mortality rates of the Intravenous trombolysis treatment 1 month Mortality rates of the Intravenous trombolysis treatment when applied in eligible ischemic stroke patients
Treatment adequacy: Intravenous trombolysis treatment 1 month Intravenous trombolysis treatment applied in eligible ischemic stroke patients
response capacity 1 day Response time for the initial evaluation and treatment
Patient safety. Complications in the recombinant tissue plasminogen activator treatment after tromobysis 1 month Recombinant tissue plasminogen activator complication rates
Patient engage 1 month Health literacy Scale